Table 3.
WT | WT + TG | HYP | HYP + TG | |
---|---|---|---|---|
Male | ||||
N | 5 | 4 | 8 | 5 |
OV/TV (%) | 0.31 ± 0.18 | 0.44 ± 0.13 | 24.66 ± 13.95* | 5.48 ± 3.36** |
BV/TV (%) | 19.6 ± 5.35 | 19.72 ± 4.37 | 87.5 ± 19.7* | 24.7 ± 18.8** |
OsTh (µm) | 1.72 ± 0.24 | 2.1 ± 0.39 | 16.02 ± 6.05* | 7.74 ± 1.06** |
TbN (per mm2) | 4.1 ± 0.75 | 4.38 ± 0.67 | 5.64 ± 0.48 | 3.87 ± 2.04 |
OV/BV (%) | 1.56 ± 0.80 | 2.20 ± 0.23 | 46.44 ± 22.02* | 25.49 ± 5.94 |
Female | ||||
N | 4 | 5 | 17 | 3 |
OV/TV (%) | 0.38 ± 0.11 | 0.29 ± 0.12 | 11.55 ± 9.4* | 2.86 ± 1.33** |
BV/TV (%) | 12.5 ± 5.02 | 8.42 ± 2.51 | 37.1 ± 18.1* | 16.9 ± 7.7 |
OsTh (lm) | 2.03 ± 0.32 | 2.11 ± 0.64 | 10.02 ± 4.64* | 6.01 ± 1.2 |
TbN (per mm2) | 2.68 ± 0.73 | 2.14 ± 0.75 | 4.5 ± 1.52 | 3.1 ± 0.5 |
OV/BV (%) | 3.17 ± 0.83 | 3.74 ± 1.88 | 27.1 ± 12.7* | 19.5 ± 10.3 |
Note: WT wild type, TG transgene, HYP hypophosphatemia, OV/TV osteoid area/tissue area, BV/TV bone volume/tissue volume, OsTh osteoid thickness, TbN trabecular number, OV/BV percentage osteoid.
p < 0.01 vs. WT;
p < 0.01 vs. same genotype without the TG